Allergan Aesthetics, an AbbVie company, announced SkinMedica’s expanded commitment to regenerative science, with investments advancing innovation, research, clinical insight, and patient experience. The initiatives include a new Regenerative Science Advisory Board, an expanded research and development facility, and new flagship retail experiences.
SkinMedica has launched the Regenerative Science Advisory Board, a collective of leading physicians, clinicians, and skin health experts from across the country. Through in-person collaboration, virtual consultations, and curated content across SkinMedica-owned platforms, the advisory board will foster scientific dialogue, share clinical best practices, and help bridge breakthrough research with everyday patient care.
The advisory board complements Allergan Aesthetics’ continued investment in SkinMedica innovation, including the recent expansion of the SkinMedica research and development lab in Irvine, California, now more than double its previous footprint. The state-of-the-art lab supports a broad range of pre-clinical research and sophisticated imaging technologies that provide deeper insight into skin biology, while SkinMedica is also leveraging artificial intelligence and machine learning to identify novel biological targets, accelerate ingredient discovery, and advance understanding of the cellular drivers of skin longevity.
SkinMedica has also launched its first in-practice flagship retail experience at select medical aesthetics practices nationwide, designed to extend the physician-guided skincare journey beyond the treatment room. The first flagship locations include Lycia Thornburg, M.D. Dermatology in Rapid City, South Dakota, and The Skin Clinic in Scottsdale, Arizona, with additional locations planned to open across key U.S. markets throughout 2026.
KEY QUOTES:
“Stemming from its origins in wound-healing research, SkinMedica was founded on the principles of regenerative skincare.”
“For more than 25 years, the brand has consistently advanced science-backed solutions, and today we’re excited to introduce initiatives that continue to reinforce its mission to support skin health from cell to surface.”
“Scientific innovation is most impactful when it is informed by the clinicians and experts who bring it to life every day. We’re honored to welcome this distinguished group of thought leaders to the SkinMedica Regenerative Science Advisory Board. Their expertise and real-world perspective will help advance scientific education, strengthen collaboration across the aesthetic community, inform future conversations around skin longevity and innovation; while ensuring we continue to translate breakthrough science into meaningful solutions for providers and patients.”
Glen Curran, Senior Vice President, Allergan Aesthetics
“The expanded SkinMedica R&D Lab reflects our commitment to advancing the future of skincare through scientific excellence, strategic collaboration, and emerging technologies.”
“By integrating advanced research capabilities with AI-enabled discovery and clinical expertise, we are accelerating our ability to transform breakthrough science into meaningful innovations that deliver for patients and providers.”
Prithwiraj Maitra, Ph.D., Vice President, Global Skincare R&D, Allergan Aesthetics
